Evidence map›Paper›PMID 28135265›Full record

ArticlePLoS genetics2017

β-Integrin de-phosphorylation by the Density-Enhanced Phosphatase DEP-1 attenuates EGFR signaling in C. elegans.

Michael Walser, Christoph Alois Umbricht, Erika Fröhli, Paolo Nanni, Alex Hajnal

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Michael WalserInstitute of Molecular Life Sciences, University of Zürich, Winterthurerstr. 190, University of Zürich, Zürich, Switzerland.ORCID 0000-0003-3506-4621
Christoph Alois UmbrichtInstitute of Molecular Life Sciences, University of Zürich, Winterthurerstr. 190, University of Zürich, Zürich, Switzerland.
Erika FröhliInstitute of Molecular Life Sciences, University of Zürich, Winterthurerstr. 190, University of Zürich, Zürich, Switzerland.
Paolo NanniFunctional Genomics Center Zürich, University of Zürich/ETH Zürich, Winterthurerstr. 190, Zürich, Switzerland.ORCID 0000-0001-8429-3557
Alex HajnalInstitute of Molecular Life Sciences, University of Zürich, Winterthurerstr. 190, University of Zürich, Zürich, Switzerland.ORCID 0000-0002-4098-3721
University of Zurich · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Density-Enhanced Phosphatase-1 (DEP-1) de-phosphorylates various growth factor receptors and adhesion proteins to regulate cell proliferation, adhesion and migration. Moreover, dep-1/scc1 mutations have been detected in various types of human cancers, indicating a broad tumor suppressor activity. During C. elegans development, DEP-1 mediates binary cell fate decisions by negatively regulating EGFR signaling. Using a substrate-trapping DEP-1 mutant in a proteomics approach, we have identified the C. elegans β-integrin subunit PAT-3 as a specific DEP-1 substrate. DEP-1 selectively de-phosphorylates tyrosine 792 in the membrane-proximal NPXY motif to promote integrin activation via talin recruitment. The non-phosphorylatable β-integrin mutant pat-3(Y792F) partially suppresses the hyperactive EGFR signaling phenotype caused by loss of dep-1 function. Thus, DEP-1 attenuates EGFR signaling in part by de-phosphorylating Y792 in the β-integrin cytoplasmic tail, besides the direct de-phosphorylation of the EGFR. Furthermore, in vivo FRAP analysis indicates that the αβ-integrin/talin complex attenuates EGFR signaling by restricting receptor mobility on the basolateral plasma membrane. We propose that DEP-1 regulates EGFR signaling via two parallel mechanisms, by direct receptor de-phosphorylation and by restricting receptor mobility through αβ-integrin activation.

Indexed as

Protein Processing, Post-TranslationalSignal TransductionAmino Acid MotifsAnimalsCaenorhabditis elegansCaenorhabditis elegans ProteinsErbB ReceptorsIntegrin beta ChainsMutationPhosphorylationReceptor-Like Protein Tyrosine Phosphatases, Class 3Caenorhabditis elegans ProteinsErbB ReceptorsIntegrin beta Chainspat-3 protein, C elegansReceptor-Like Protein Tyrosine Phosphatases, Class 3

Identifiers

PMID28135265
PMCPMC5305270
OpenAlexW2581254607

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.